Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Earnings_Time Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::576434817.png) EarningsTime [@Earnings_Time](/creator/twitter/Earnings_Time) on x 8375 followers
Created: 2025-05-01 12:46:20 UTC

Alnylam Pharmaceuticals, $ALNY, Q1-25. Results:
🟢 +2% Pre-Market ($268.56)

📊 Adj. EPS: -$0.01 🟢
💰 Revenue: $594M 🟢
🔎 FDA approved AMVUTTRA for ATTR-CM; strong commercial launch underway and sixth RNAi therapy, Qfitlia, also approved in U.S.

![](https://pbs.twimg.com/media/Gp3VGTXW8AAYMBJ.png)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1917923541888151925/c:line.svg)

**Related Topics**
[underway](/topic/underway)
[$594m](/topic/$594m)
[eps](/topic/eps)
[$alny](/topic/$alny)
[alnylam pharmaceuticals inc](/topic/alnylam-pharmaceuticals-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/Earnings_Time/status/1917923541888151925)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Earnings_Time Avatar EarningsTime @Earnings_Time on x 8375 followers Created: 2025-05-01 12:46:20 UTC

Alnylam Pharmaceuticals, $ALNY, Q1-25. Results: 🟢 +2% Pre-Market ($268.56)

📊 Adj. EPS: -$0.01 🟢 💰 Revenue: $594M 🟢 🔎 FDA approved AMVUTTRA for ATTR-CM; strong commercial launch underway and sixth RNAi therapy, Qfitlia, also approved in U.S.

XXX engagements

Engagements Line Chart

Related Topics underway $594m eps $alny alnylam pharmaceuticals inc stocks healthcare

Post Link

post/tweet::1917923541888151925
/post/tweet::1917923541888151925